2171 — CARsgen Therapeutics Holdings Share News
0.000.00%
Last trade - 00:00- HK$6.66bn
- HK$5.18bn
- CNY125.66m
Brief: Carsgen Therapeutics Says U.S. Unit Passed Inspections Of Its Current Good Manufacturing Practice Facility
Brief: CARsgen Therapeutics Says U.S. FDA Granted Regenerative Medicine Advanced Therapy Designation To CT041
Brief: Carsgen Receives CTA Authorization From Health Canada For Car T-Cell Product
Brief: Carsgen Therapeutics Says Clinical Trial Application For CT041 Authorised By Health Canada
Brief: CARsgen Therapeutics Says CT041 Granted Prime Eligibility By EMA For Treatment Of Gastric/Gastroesophageal Junction Cancer
Brief: Carsgen Therapeutics Announces Inclusion Of Co As An Eligible Stock Of Shenzhen-Hong Kong Stock Connect
Brief: Carsgen Therapeutics HY Net Loss Rmb4,394 Million
China's CARsgen Therapeutics plunges in Hong Kong debut